Skip to content
  • Global Key Solutions is now KeyPedia →
  • Independent Study of FDA Correspondence Finds Earliest CDER Warning Letter Citing AI Use →
  • KeyPedia Launches openFDA MCP Connector With an "Elsa for Industry" Approach →
  • KeyPedia Listed in TPRA’s TPRM Tools List →
  • Global Key Solutions is now KeyPedia →
  • Independent Study of FDA Correspondence Finds Earliest CDER Warning Letter Citing AI Use →
  • KeyPedia Launches openFDA MCP Connector With an "Elsa for Industry" Approach →
  • KeyPedia Listed in TPRA’s TPRM Tools List →
KeyPediaKeyPedia
  • Company
  • Platform
  • Media
  • KeyPedia Lite
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Nang Kuang Pharmaceutical Co., Ltd.
FDA Inspection•Nang Kuang Pharmaceutical Co., Ltd.•September 5, 2017

Nang Kuang Pharmaceutical Co., Ltd. – FDA Inspection, Sep 5, 2017

Record Details

This FDA Inspection record concerns Nang Kuang Pharmaceutical Co., Ltd., with an inspection on September 5, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Nang Kuang Pharmaceutical Co., Ltd.
Inspection Date
September 5, 2017
Product Type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Satheesh Thomas

ID · eb04c0cf-58c3-4bed-b40d-6788cb32ce7f

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1024786
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued

FDA Citations

6
  1. 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
  2. 21 CFR 211.84(d)(2)Testing Each Component for Conformity with Specs
  3. 21 CFR 211.25(a)Training , Education , Experience overall
  4. 21 CFR 211.194(a)(4)Complete Test Data
  5. 21 CFR 211.113(b)Validation lacking for sterile drug products
  6. 21 CFR 211.165(e)Test methods

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Nang Kuang Pharmaceutical Co., Ltd.

5
DateClassificationOfficeProject area
November 7, 2024Not classifiedOffice of Inspections and Investigations
April 2, 2024OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
November 6, 2018VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
April 24, 2015VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
August 30, 2013VAICenter for Drug Evaluation and ResearchDrug Quality Assurance

Other documents for Nang Kuang Pharmaceutical Co., Ltd.

5
Document
FDA Inspection 1260207 · November 7, 2024 
FDA Inspection 1236762 · April 2, 2024 
FDA Inspection 1072749 · November 6, 2018 
FDA Inspection 923879 · April 24, 2015 
FDA Inspection 851643 · August 30, 2013 
View Company ProfileHave an account? Sign in to open in Dashboard

Or discuss it with

What you get

  1. A document

    One file.

    • One FDA document, such as a Form 483
    • Yours for life in your Library
    • Each has its own price
    here
  2. The profile

    All the documents, plus intelligence about the company.

    • Every Nang Kuang Pharmaceutical Co., Ltd. document on file
    • The KRA score, which a single document does not include
    • Observations and inspection history
  3. Access

    This, for every company on KeyPedia.

    • Combine profiles in one search
    • Search across any modality: products, industry types, drugs, devices and recalls
    • Track everything as it changes
    • Other agencies too, such as EMA, Health Canada and UK MHRA
    Browse free in KeyPedia Lite
KeyPedia
The intelligence layer for life sciences
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
Quick Links
HomePlatformUse CasesHardwarePricingResearchOur TechnologyFAQMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPrograms & Partnerships
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.